(Q35212601)

English

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Pancras C.W. Hogendoorn

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Verweij J

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

van Oosterom A

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Judson I

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Rodenhuis S

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

van der Graaf W

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Le Cesne A

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

di Paola ED

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Brown M

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Nielsen OS

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2006-2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Importance of surgical resection in the successful management of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The local management of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Soft tissue sarcoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal stromal tumors: recent advances in understanding of their biology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The histopathological differential diagnosis of gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate--a new oral targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900836-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(02)00836-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957454%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

reason for deprecated rank

incorrect identifier value

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35212601&oldid=1955160790"